Blocking a receptor in the brain called mGluR5 is considered a potential strategy for treating a number of disorders, including major depression, Parkinson’s disease and Fragile X Syndrome.
Read More
Scientists have discovered that they can improve memory and reduce repetitive behavior in animal models of Fragile X syndrome by adjusting the levels of a signaling protein called PIKE. The…
Read More
With the aid of a NARSAD Grant, a new study of adolescents at high risk for developing psychosis found that their long-term functioning is not solely dependent on the progression or development of…
Read More
In the continuing search for glitches in brain development that may give rise later on to serious illnesses such as schizophrenia, autism spectrum disorder (ASD) and epilepsy, research done by a team…
Read More
Momentum is building in the largest experiment ever in schizophrenia research: 13 more regions in the human gene code, or genome, have been identified as being associated with schizophrenia in the…
Read More
